A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Clinical trial NCT06730347 · RECRUITING

Trial details

NCT number: NCT06730347
Sponsor: MacroGenics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma Clear Cell Adenocarcinoma of Ovary Clear Cell Adenocarcinoma of Vulva Clear Cell Adenocarcinoma of Vagina Clear Cell Adenocarcinoma of Cervix Clear Cell Adenocarcinoma of Uterus Clear Cell Adenocarcinoma of Fallopian Tube Clear Cell Adenocarcinoma of Peritoneum Endometrial Cancer

Start date: 2025-05-01
Primary completion: 2027-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.